These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8585928)

  • 41. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
    J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages.
    Segura JJ; Guerrero JM; Goberna R; Calvo JR
    Regul Pept; 1992 Feb; 37(3):195-203. PubMed ID: 1372999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. VIP modulates intracellular calcium oscillations in human lymphoblasts.
    Anton PA; Shanahan F; Sun XP; Diehl D; Kodner A; Mayer EA
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):429-46. PubMed ID: 8227970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional type II VIP-PACAP receptors in human airway epithelial-like cells.
    Lindén A; Yoshihara S; Cardell LO; Kaneko T; Stjärne P; Nadel JA
    Peptides; 1997; 18(6):843-6. PubMed ID: 9285933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of cyclic AMP and inositol phosphate production in rat prostatic cultures by VIP/PACAP, ATP, and carbachol: role in prostatic proliferation.
    Guijarro LG; Juarranz MG; Marinero MJ; Pajuelo L; Carmena MJ; Prieto JC
    Ann N Y Acad Sci; 1996 Dec; 805():723-8. PubMed ID: 8993468
    [No Abstract]   [Full Text] [Related]  

  • 47. The vasoactive intestinal peptide receptor-effector system is developmentally regulated in rat jejuno-ileal epithelial cells.
    Fernandez-Moreno MD; Diaz-Juarez JL; Fernandez-Gonzalez MA; Sanchez-Franco F; Prieto JC
    Biochem Int; 1988 Feb; 16(2):331-7. PubMed ID: 2835052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rat and guinea pig pancreatic acini possess both VIP(1) and VIP(2) receptors, which mediate enzyme secretion.
    Ito T; Hou W; Katsuno T; Igarashi H; Pradhan TK; Mantey SA; Coy DH; Jensen RT
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G64-74. PubMed ID: 10644563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new vasoactive intestinal peptide antagonist discriminates VIP receptors on guinea pig trachea and human neuroblastoma cells.
    Leroux F; Goossens JF; Pommery N; Hénichart JP
    Regul Pept; 1994 Jul; 52(2):119-28. PubMed ID: 7972935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The autocrine function of vasoactive intestinal peptide on human neuroblastoma cell growth and differentiation.
    Pence JC; Shorter NA
    Arch Surg; 1993 May; 128(5):591-5. PubMed ID: 8387768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.
    Hashimoto H; Ogawa N; Hagihara N; Yamamoto K; Imanishi K; Nogi H; Nishino A; Fujita T; Matsuda T; Nagata S; Baba A
    Mol Pharmacol; 1997 Jul; 52(1):128-35. PubMed ID: 9224822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
    Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
    Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasoactive intestinal peptide stimulates ciliary motility in rabbit tracheal epithelium: modulation by neutral endopeptidase.
    Sakai N; Tamaoki J; Kobayashi K; Kanemura T; Isono K; Takeyama K; Takeuchi S; Takizawa T
    Regul Pept; 1991 Jun; 34(1):33-41. PubMed ID: 1650011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
    Prieto JC; Guerrero JM; de Miguel C; Goberna R
    Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates VIP/PACAP receptor activity.
    De Maria S; Metafora S; Metafora V; Morelli F; Robberecht P; Waelbroeck M; Stiuso P; De Rosa A; Cozzolino A; Esposito C; Facchiano A; Cartenì M
    Eur J Biochem; 2002 Jul; 269(13):3211-9. PubMed ID: 12084061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1.
    Emami S; Gespach C; Forgue-Lafitte ME; Broer Y; Rosselin G
    Life Sci; 1983 Aug; 33(5):415-23. PubMed ID: 6192308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: evidence for involvement of a cyclic GMP-dependent mechanism.
    Schaad NC; Vanecek J; Rodriguez IR; Klein DC; Holtzclaw L; Russell JT
    Mol Pharmacol; 1995 May; 47(5):923-33. PubMed ID: 7538196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parallel activation of cyclic AMP phosphodiesterase and cyclic AMP-dependent protein kinase in two human gut adenocarcinoma cells (HT 29 and HRT 18) in culture, by vasoactive intestinal peptide (VIP) and other effectors activating the cyclic AMP system.
    Mangeat P; Marvaldi J; Ahmed OA; Marchis-Mouren G
    Regul Pept; 1981 Mar; 1(6):397-414. PubMed ID: 6262879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains.
    Couvineau A; Rouyer-Fessard C; Darmoul D; Maoret JJ; Carrero I; Ogier-Denis E; Laburthe M
    Biochem Biophys Res Commun; 1994 Apr; 200(2):769-76. PubMed ID: 8179610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
    Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
    Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.